(Q44146950)

30 November 2017

Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial (English)

1 reference

multicenter clinical trial

30 November 2017

1 reference

1 reference

1 reference

Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group

series ordinal

1

1 reference

PubMed ID

12243918

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

30 November 2017

1 reference

30 November 2017

360

1 reference

30 November 2017

9336

1 reference

30 November 2017

835-841

1 reference

Meta-analysis of intervention trials on case-management of pneumonia in community settings

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Don't keep taking the tablets?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Short-Course antimicrobial therapy for upper respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Adherence to cotrimoxazole treatment for acute lower respiratory tract infections in rural Bangladeshi children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Azithromycin: 3-day versus 5-day course in the treatment of respiratory tract infections in children. Croatian Azithromycin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan Co-trimoxazole Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

A randomized double blind controlled trial comparing two amoxycillin regimens in the treatment of acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Azithromycin. A review of its use in paediatric infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Azithromycin: the first of the tissue-selective azalides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

The macrolides: erythromycin, clarithromycin, and azithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Rational prescribing of antibacterials in ambulatory children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Epidemiology of penicillin resistant pneumococci in Iceland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Hungary sees an improvement in penicillin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Diagnoses of acute lower respiratory tract infections in children in Rawalpindi and Islamabad, Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Etiology of acute lower respiratory tract infections in Gambian children: I. Acute lower respiratory tract infections in infants presenting at the hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Etiology of acute lower respiratory tract infection in children from Alabang, Metro Manila.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Differentiating bacterial from viral pneumonias in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

Accuracy of radiographic differentiation of bacterial from nonbacterial pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909994-4

7 January 2021

10.1016/S0140-6736(02)09994-4

Identifiers

DOI

1 reference

30 November 2017

1 reference

PubMed ID

12243918